Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02104414 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy
A Phase 4 study, sponsored by St. Luke's-Roosevelt Hospital Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT02104414 is a Phase 4 study that was terminated before completion, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 11 participants.
The verdict
NCT02104414, a Phase 4 study, was terminated before completion, sponsored by St. Luke's-Roosevelt Hospital Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain relief than both bupivacaine hcl and the control.
Interventions
- DRUG Exparel
- DRUG Normal Saline
- DRUG Bupivacaine HCl with Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02104414
The ClinicalTrials.gov registry entry for NCT02104414 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exparel is the first listed.
NCT02104414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02104414 about?
NCT02104414 is a clinical study titled "Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy". The purpose of this study is to compare the quality and duration of pain relief after a hemorrhoidectomy, provided by locally administered liposomal bupivacaine versus bupivacaine hcl or control with saline. It is hypothesized that liposomal bupivacaine will provide more effective postoperative pain...
What is the current status of trial NCT02104414?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2014-04. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02104414?
The interventions under investigation include: Exparel (DRUG), Normal Saline (DRUG), Bupivacaine HCl with Epinephrine (DRUG).
Who is sponsoring clinical trial NCT02104414?
This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.